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Abstract
Background: There is a lack of knowledge about the pattern of symptom reporting in the general population as
most research focuses on specific diseases or symptoms. The number of musculoskeletal pain sites is a strong
predictor for disability pensioning and, hence, is considered to be an important dimension in symptom reporting.
The simple method of counting symptoms might also be applicable to non-musculoskeletal symptoms, rendering
further dimensions in describing individual and public health. In a general population, we aimed to explore the
association between self-reported non-musculoskeletal symptoms and the number of pain sites.
Methods: With a cross-sectional design, the Standardised Nordic Questionnaire and the Subjective Health
Complaints Inventory were used to record pain at ten different body sites and 13 non-musculoskeletal symptoms,
respectively, among seven age groups in Ullensaker, Norway (n = 3,227).
Results: Results showed a strong, almost linear relationship between the number of non-musculoskeletal
symptoms and the number of pain sites (r = 0.55). The number and type of non-musculoskeletal symptoms had an
almost equal explanatory power in the number of pain sites reported (27.1% vs. 28.2%).
Conclusion: The linear association between the number of non-musculoskeletal and musculoskeletal symptoms
might indicate that the symptoms share common characteristics and even common underlying causal factors. The
total burden of symptoms as determined by the number of symptoms reported might be an interesting generic
indicator of health and well-being, as well as present and future functioning. Research on symptom reporting
might also be an alternative pathway to describe and, possibly, understand the medically unexplained
multisymptom conditions.
Keywords: Epidemiology, Cross-sectional, General population, Musculoskeletal pain, Medically unexplained
symptoms
Background
Patients present to their general practitioners (GPs) with
symptoms, not a diagnosis. Despite this, symptomatol-
ogy is traditionally viewed in the context of predefined
illness. Most research focuses on a particular disease or
on selected symptoms. Knowledge about the pattern of
symptom reporting may be of importance to decision
making in general practice; it may affect referral patterns
and the tendency to initiate further tests.
In a recent article describing the symptom iceberg in
the UK population, prevalence figures for common
symptoms were presented in relation to individual char-
acteristics and chronic conditions [1]. In a review,
Kroenke has shown that 80% of individuals in a general
population will experience at least one symptom during
a given month [2]. Furthermore, he states that at least
one third of the symptoms reported in primary care and
in population-based studies are “medically unexplained”,
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for classifying symptoms.
Symptoms for which there is no evident medical
explanation pose a special challenge to the health care
system in general, to GPs in particular, as well as to
society as a whole due to costs related to utilisation of
health care and welfare resources[2-4]. Several terms
have been launched to describe symptoms without plau-
sible medical explanations [5,6]. “Medically unexplained
symptoms” (MUS) is one of the most recent terms,
although consensus regarding its applicability remains to
be established [7]. Research in this field has traditionally
focused on the individual syndromes. While a GP will
face all syndromes, other clinical specialties seem to
have their own “medically unexplained syndrome”, such
as fibromyalgia (rheumatology), chronic fatigue syn-
drome (neurology, infectious medicine), and irritable
bowel disease (gastroenterology) [8]. Many researchers
have pointed out the substantial symptom overlap
between these syndromes, which implies that many
patients meet the criteria listed for several of the syn-
dromes [9-14].
Results from the Ullensaker study on self-reported mus-
culoskeletal pain have shown that reporting a single pain
site or none at all is rare, and almost two out of five indivi-
duals reported pain from at least five out of ten listed pain
sites during the last year [15]
. Furthermore, a strong and
linear relationship between the number of pain sites and
functional ability has been described [16]. The number of
pain sites is also a strong predictor for disability pension-
ing 14 years later [17]. It is well known that some indivi-
duals with musculoskeletal symptoms also report other
common symptoms. For example, the non-musculoskele-
tal symptoms are incorporated in the new preliminary
diagnostic criteria for fibromyalgia [18,19]. Furthermore,
longitudinal studies in the UK have shown an association
between persistence of chronic widespread pain and the
reporting of other somatic symptoms reported in assess-
ment of somatisation disorder [20-22].
When analysing symptoms presented in medical
encounters, physicians need more insight into symptom
reporting as a phenomenon in itself and as background
knowledge. As a counterweight to research focusing on
further subdivision of existing syndromes, one approach is
to examine the reporting of common symptoms in a gen-
eral population. Symptom reporting in the population
might also be a way of describing and possibly under-
standing medically unexplained symptoms and syndromes.
The association between musculoskeletal pain and the
continuum of other common symptoms, regardless of
their innate nature, remains to be explored. This article
aims to explore the association between self-reported
non-musculoskeletal symptoms and musculoskeletal
pain.
Methods
Study design and sample
This article is based on data from the Ullensaker Study,
a cohort study focusing primarily on the epidemiology
of musculoskeletal pain. Ullensaker is a suburban muni-
cipality, 40 km northeast of Oslo, Norway. Data for this
study were collected in 2004 by sending a self-adminis-
tered questionnaire to all inhabitants in the seven age
groups: 24-26, 34-36, 44-46, 54-56, 64-66, 74-76, and
84-86 year-olds. A reminder was sent to non-responders
after 6 weeks.
The Ullensaker study was approved by the Regional
Committee of Research Ethics in Norway.
Variables
We used the validated Standardised Nordic Question-
naire (SNQ) [23] to record musculoskeletal symptoms.
Respondents were asked to report whether they had
experienced pain or discomfort in any of ten different
body regions during the last 7 days: head, neck,
shoulder, elbow, hand/wrist, upper back, lower back,
hip, knee, and ankle/foot. Response categories were
restricted to ‘no’ and ‘yes’. A body manikin was sup-
plied to illustrate the location of the body regions. We
constructed a simple sum score by counting the num-
ber of musculoskeletal pain sites (NPS), ranging from 0
to 10.
Non-musculoskeletal symptoms were a selection of 13
of the 29 items included in the validated Subjective
Health Complaints Inventory (SCH) [24], which were
not covered by the SNQ. Respondents were to report
whether or not they had experienced any of the follow-
ing complaints during the last 30 days: palpitations/
extra heartbeats, chest pain, breathing difficulties, heart
burn, stomach discomfort, diarrhoea, constipation,
eczema, tiredness, dizziness, anxiety, depression, and
sleep problems. For each item, four response categories
were available: not at all, a little, some, and severe. Dur-
ing analyses, the answers were dichotomized into ‘not at
all’ ( c o d e0 )v s .t h er e s t( c o d e1 ) ,a l l o w i n ga no v e r a l l
sum score of the number of non-musculoskeletal symp-
toms (NN-MS, ranging from 0 to 13).
We also constructed a sum score for the total number
of symptoms reported by adding NN-MS and NPS
scores, ranging from 0 to 23.
Statistical analyses
We performed the following imputation procedures. A
number of respondents only ticked “yes” or “no” for
some pain sites (15.3%) and other symptoms (9.0%), and
did not tick for the rest. For blank answers we assumed
that the symptom/pain was not present and they were
consequently coded as “not present”. Imputations were
done for a total of 21.2% of the respondents. To control
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the results, we performed sensitivity analyses where all
analyses were performed on non-imputated data.
Frequencies and percentages were used to describe the
prevalence of NPS and NN-MS, and Pearson’sc o r r e l a -
tion analysis was used to describe the correlation
between the two scores.
The following linear regression analyses were per-
formed after checking for multicollinearity between
symptoms, all using NPS as the dependent variable.
Model I assessed the explanatory power of NN-MS,
while controlling for age and gender. In model II NPS
was seen as a function of all the 13 non-musculoskeletal
symptoms individually, adjusted for age and gender. In
model III, the 13 non-musculoskeletal symptoms were
modelled individually, controlling for the remaining 12
symptoms in addition to age and gender.
Unstandardised regression coefficients (b- values) are
presented, with 95% confidence intervals (obtained using
Agresti-Coull intervals from an online calculator) and
multiple correlation coefficients, R
2.We also performed
regression analyses assessing the explanatory power of
NN-MS in NPS when including only non-musculoskele-
tal symptoms affecting the respondent to “some” and
“severe” degree, and to “severe” degree, respectively.
All analyses were performed using SPSS for Windows
(version 16).
Results
Study sample
The questionnaire was sent to 6,105 persons, and after
one reminder, 3,325 individuals responded, giving a
response rate of 54.4%. Individuals who had not
answered any of the questions on pain and those who
had not answered any questions on non-musculoskeletal
symptoms were excluded (n = 98), resulting in a final
sample of 3,227 individuals (52.9% of the original sample
size). The participation rate was higher in women (59%)
than men (49%), and higher in middle-aged groups for
both genders [14]. Of respondents, 54.9% were women
and 45.1% men. The distribution of respondents within
age groups was as follows (the percentage within each
age group in our census population in parentheses[25]):
24-26: 9.8% (16.5%), 34-36: 29.2% (25.2%), 44-46: 18.5%
(18.7%), 54-56: 20.6% (17.8%), 64-66: 13.5% (11.0%), 74-
76: 7.0% (7.4%), and 84-86 year olds: 1.5% (3.2%).
Accordingly, non-responders are mostly to be found
among the youngest and oldest age groups.
The number of symptoms
The respondents reported a mean of 2.3 pain sites (95%
CI 2.2-2.4), women 2.8 (95% CI 2.6-2.9), and men 1.8
(95% CI 1.7-1.9). Table 1 shows the prevalence of NPS.
Table 2 shows the prevalence of NN-MS.
The mean NN-MS was 3.7 (95% CI 3.6-3.8), 4.0 for
women (95% CI 3.8-4.1), and 3.3 for men (95% CI
3.2-3.4).
The mean total number of symptoms (NPS + NN-MS)
was 6.0 out of a maximum of 23 (95% CI 5.8-6.2).
Women reported 6.7 symptoms (95% CI 6.5-7.0) and
men, 5.1 symptoms (95% CI 4.9-5.3) (Table 3). Of the
participants, 22.6% (95% CI 21.2-24.0) had 10 symptoms
or more (women 27.8% (95% CI 25.8-30.0), men 16.0%
(95% CI 14.4-18.3)).
The association between NN-MS and NPS
A simple correlation analysis showed a strong association
between NN-MS and NPS (r = 0.55), and we found an
Table 1 Prevalence of number of pain sites (NPS) by
gender
NPS Men (N = 1455) Women (N = 1772) Total (N = 3227)
%(95%CI) %(95%CI) %(95%CI)
0 38.4 (36.2 to 41.2) 23.2 (21.3 to 25.2) 30.1 (28.5 to 31.7)
1 18.2 (16.3 to 20.3) 15.7 (14.1 to 17.5) 16.8 (15.5 to 18.1)
2 12.4 (10.8 to 14.2) 14.6 (13.0 to 16.3) 13.5 (12.4 to 14.8)
3 12.8 (11.2 to 14.6) 13.0 (11.6 to 14.7) 12.9 (11.8 to 14.1)
4 7.7 (6.4 to 9.2) 10.7 (9.31 to 12.2) 9.3 (8.3 to 10.4)
5 4.5 (3.5 to 5.7) 7.7 (6.5 to 9.0) 6.2 (5.4 to 7.1)
6 3.0 (2.3 to 4.1) 5.6 (4.6 to 6.8) 4.4 (3.8 to 5.2)
7 1.2 (0.7 to 1.9) 4.2 (3.3 to 5.2) 2.8 (2.3 to 3.5)
8 0.7 (0.4 to 1.3) 2.1 (1.6 to 2.9) 1.5 (1.1 to 2.0)
9 0.8 (0.4 to 1.4) 1.7 (1.2 to 2.4) 1.3 (0.9 to 1.7)
10 0.8 (0.4-1.4) 1.6 (1.1 to 2.3) 1.2 (0.9 to 1.7)
NPS Number of pain sites: CI Confidence Interval
Table 2 Prevalence of number of non-muscular
symptoms (NN-MS) by gender
NN-MS Men (N = 1455) Women (N = 1772) Total (N = 3227)
% (95% CI) % (95% CI) % (95% CI)
0 16.8 (15.0 to 18.8) 9.9 (8.6 to 11.4) 13.0 (11.9 to 14.2)
1 14.7(13.0 to 16.7) 12.4 (11.0 to 14.0) 13.4 (12.3 to 14.6)
2 14.1 (12.4 to 16.0) 15.1 (13.5-16.9) 14.6 (13.5 to 15.9)
3 13.6 (11.9 to 15.4) 11.9 (10.4 to 13.4) 12.6 (11.5 to 13.8)
4 12.0 (10.5 to 13.8) 11.6 (10.2 to 13.2) 11.8 (10.7 to 13.0)
5 8.7 (7.4 to 10.3) 11.1 (9.7 to 12.7) 10.0 (9.0 to 11.1)
6 7.1 (5.8 to 8.5) 7.6 (6.4 to 8.9) 7.3 (6.5 to 8.3)
7 5.8 (4.7 to 7.2) 7.5 (6.4 to 8.8) 6.7 (5.9 to 7.6)
8 2.8 (2.0 to 3.8) 5.1 (4.2 to 6.2) 4.0 (3.4 to 4.8)
9 2.1 (1.5 to 3.0) 3.1 (2.3 to 4.0) 2.6 (2.1 to 3.2)
10 1.7 (1.2 to 2.6) 2.3 (1.7 to 3.1) 2.1 (1.6 to 2.6)
11 0.6 (0.3 to 1.1) 1.5 (1.0 to 2.2) 1.1 (0.8 to 1.5)
12 0.6 (0.3 to 1.2) 0.7 (0.4 to 1.39 0.7 (0.4 to 1.0)
13 0.1 (<0.0 to 0.4) 0.2 (0.03 to 0.5) 0.1 (0.04 to 0.33)
NN-MS Number of non-muscular symptoms; CI Confidence Interval
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reporting any pain sites reported a mean of approxi-
mately two non-musculoskeletal symptoms. Respondents
with ten pain sites reported a mean of approximately
eight non-musculoskeletal symptoms. Results for men
and women followed a similar trend.
NN-MS, adjusted for age and gender explained 33.0%
o ft h ev a r i a n c ei nN P S( R
2 =0 . 3 3 ,p <0 . 0 0 1 ,M o d e lI ) ,
of which the NN-MS -score alone had an explanatory
power of 27.1%.
Multicollinearity between symptoms in the analyses was
not revealed. The maximum correlation found was 0.56
(between depression and anxiety), and the collinearity
indicators Tolerance and Variance Inflation Factors (VIF)
were well within the limits of concern for all symptoms
involved in the analysis. Depression had the lowest toler-
ance (= 0.59) and the highest VIF (= 1.69).
When modelling NPS as a function of the 13 individual
non-musculoskeletal symptoms, age and gender (Model
II), the explanatory power was 33.8% (R
2 = 0.338, p <
0.001). The 13 non-musculoskeletal symptoms alone
Table 3 Prevalence of total symptoms (number of pain sites (NPS) + number of non-muscular symptoms (NN-MS)) by
gender
Total symptoms Men (N = 1455) Women (N = 1772) Total (N = 3227)
(NPS+ NN-MS) % (95% CI) % (95% CI) % (95% CI)
0 11.5 (9.9 to 13.2) 5.4 (4.4 to 6.5) 8.1 (7.2 to 9.1)
1 11.7 (10.2 to 13.5) 8.0 (6.8 to 9.4) 9.7 (8.7 to 10.7)
2 9.6 (8.1 to 11.2) 9.4 (8.1 to 10.4) 9.4 (8.5 to 10.5)
3 11.2 (9.6 to 12.9) 7.5 (6.4 to 8.8) 9.1 (8.2 to 10.2)
4 9.1 (7.8 to 10.7) 8.7 (7.5 to 10.1) 8.9 (7.9 to 9.9)
5 8.4 (7.1 to 9.9) 7.8 (6.7 to 9.2) 8.1 (7.2 to 9.1)
6 6.9 (5.7 to 8.3) 7.2 (6.1 to 8.5) 7.0 (6.2 to 8.0)
7 6.4 (5.3 to 7.8) 7.2 (6.1 to 8.5) 6.8 (6.0 to 7.7)
8 5.3 (4.3 to 6.6) 6.1 (5.1 to 7.4) 5.8 (5.0 to 6.6)
9 4.4 (3.4 to 5.6) 4.9 (3.9 to 6.0) 4.6 (3.9 to 5.4)
10 4.7 (3.7 to 5.9) 5.6 (4.7 to 6.8) 5.2 (4.5 to 6.0)
11 3.1 (2.3 to 4.2) 4.7 (3.8 to 5.8) 4.0 (3.3 to 4.7)
12 2.2 (1.5 to 3.0) 4.0 (3.1 to 5.0) 3.1 (2.6 to 3.8)
13 2.1 (1.5 to 3.0) 3.6 (2.8 to 4.6) 2.9 (2.4 to 3.6)
14 1.3 (1.8 to 2.1) 2.1 (1.5 to 2.9) 1.7 (1.3 to 2.3)
15 1.8 (0.5 to 1.5) 2.5 (1.8 to 3.3) 1.7 (1.3 to 2.3)
16 0.7 (0.4 t 1.3) 1.6 (1.1 to 2.3) 1.2 (0.9 to 1.6)
17 0.6 (0.3 to 1.2) 1.6 (1.1 to 2.4) 1.2 (0.9 to 1,6)
18 0.1 (0-0.5) 0.9 (0.5 to 1.5) 0.6 (0.4 to 0.9)
19 0.4 (0.1 to 0.8) 0.4 (0.2 to 0.8) 0.4 (0.2 to 0.7)
20 0.1 (0 to 0.5) 0.2 (0.1 to 0.6) 0.2 (0.1 to 0.4)
21 0 (0 to0.2) 0.4 (1.2 to 0.8) 0.2 (0.1 to 0.5)
22 0.1 (0 to 0.5) 0.2 (0.1 to 0.6) 0.2 (0.1 to 0.4)
23 0 (0 to 0.2) 0 (0 to 0.2) 0 (0 to 0.1)
NPS Number of pain sites; NN-MS Number of non-muscular symptoms; CI Confidence Interval

Figure 1 The association between the number of non-
musculoskeletal symptoms (NN-MS) and the number of pain
sites (NPS). The figure is based on the mean NN-MS score for each
NPS-score.
Tschudi-Madsen et al. BMC Musculoskeletal Disorders 2011, 12:285
http://www.biomedcentral.com/1471-2474/12/285
Page 4 of 8explained 28.2% of the variance in NPS. The individual
symptoms explained between 2.4% (eczema) and 12.0%
(dizziness) of the variance in NPS. Dizziness, breathing
difficulties and chest pain were the symptoms that gave
the greatest increase in NPS with b = 1.86, 1.78, and 1.76,
respectively (Table 4) The b-values indicate the increase
in NPS-score if the symptom analysed is present vs. not
present.
We found that the prevalence of each non-musculos-
keletal symptom was almost linearly related to NPS
(Figure 2). The lines for individual non-musculoskeletal
symptoms had similar slopes but different intercepts.
Tiredness had the highest intercept; approximately 40%
reported this symptom at zero pain sites, whereas chest
pain had the lowest intercept, with approximately 5%
reporting this symptom at zero pain sites.
Finally, we entered the individual non-musculoskeletal
symptoms in the model, controlling for the remaining 12
non-musculoskeletal symptoms in addition to age and
gender (Model III, Table 4). The explanatory power of
the individual symptoms was greatly reduced compared
to Model II, explaining from 0.1% to 1.9% of the variance
in NPS. The symptoms giving the greatest increase in
NPS were dizziness and sleep problems (b =0 . 7 8a n d
0.74 respectively).
In the questionnaire, non-musculoskeletal symptoms
were graded into levels of severity. Including only symp-
toms graded as affecting the respondent to “some” and
“severe” degree, the explanatory power was reduced to
28.9%. Including “severe” symptoms only, NN-MS
explained 17.5% of the variance in NPS.
Sensitivity analyses, where all analyses were performed
on non-imputated data, showed that the imputation
procedures had a tendency to weaken rather than
strengthen the associations presented in our results
(data not shown).
Discussion and conclusions
Key findings
We have found that a substantial part of the population
report a great number of symptoms. There is a strong,
almost linear relationship between the number of non-
musculoskeletal symptoms (NN-MS) and the number of
pain sites (NPS). Similarly, the prevalence of the indivi-
dual non-musculoskeletal symptoms increased with
increasing NPS.
NN-MS explained 27.1% of the variance in NPS. In
comparison, a model comprising the 13 individual non-
musculoskeletal symptoms explained 28.2% of the var-
iance in NPS. The individual symptoms explained
between 2.4% and 12.0% of the variance in NPS, when
controlling for age and gender.
Methodological considerations
Study sample and design
This study is population-based and has a relatively large
sample size. However, some precautions should be con-
sidered when interpreting the results due to the modest
response rate. Some studies have pointed out that
responders tend to have better health than drop-outs
(“the healthy volunteer effect”), [26-28]. On the other
hand, it might be that individuals experiencing symptoms
Table 4 Linear regression analyses of the association between number of pain sites (NPS) and individual non-muscular
symptoms
Model II
1 Model III
2
Symptom b (95% CI) R
2 p-value b (95% CI) R
2 p-value
Palpitations 1.33 (1.14-1.52) 0.051 <0.001 0.22 (0.03-0.40) 0.001 0.020
Chest pain 1.76 (1.56-1.96) 0.078 <0.001 0.51 (0.31-0.72) 0.005 <0.001
Breathing difficulties 1.78 (1.58-1.98) 0.081 <0.001 0.53 (0.33-0.73) 0.005 <0.001
Heart burn 1.08 (0.91-1.25) 0.044 <0.001 0.20 (0.05-0.36) 0.001 0.12
Stomach discomfort 1.67 (1.49-1.85) 0.085 <0.001 0.51 (0.33-0.70) 0.006 <0.001
Diarrhea 1.10 (0.93-1.27) 0.043 <0.001 0.35 (0.20-0.51) 0.004 <0.001
Constipation 1.34 (1.10-1.57) 0.035 <0.001 0.43 (0.22-0.64) 0.003 <0.001
Eczema 0.93 (0.73-1.13) 0.024 <0.001 0.40 (0.22-0.57) 0.004 <0.001
Tiredness 1.52 (1.36-1.68) 0.093 <0.001 0.43 (0.28-0.59) 0.006 <0.001
Dizziness 1.86 (1.69-2.03) 0.120 <0.001 0.78 (0.61-0.95) 0.017 <0.001
Anxiety 1.63 (1.45-1.82) 0.080 <0.001 0.26 (0.05-0.47) 0.001 0.14
Depression 1.51 (1.35-1.68) 0.089 <0.001 0.31 (0.12-0.49) 0.002 0.001
Sleep problems 1.57 (1.41-1.72) 0.104 <0.001 0.74 (0.59-0.89) 0.019 <0.001
b unstandardised regression coefficient; R
2 multiple correlation coefficient
1 Model II: Dependent variable: Number of pain sites (NPS). Independent variable: Individual non-muscular symptoms while controlling for age and gender
2 Model III: Dependent variable: Number of pain sites (NPS). Independent variable: individual non-muscular symptoms while controlling for the remaining 12 non-
muscular symptoms in addition to age and gender
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therefore, decided to participate [29]. In addition, another
Norwegian population survey found no differences in
lifestyle factors between responders and non-responders
[30]. We have no data on symptoms experienced by non-
responders and are, therefore, unable to draw conclu-
sions about the representability of participants’ reporting
of symptoms. Higher response rates in the groups report-
ing most symptoms (i.e. women and middle-aged) can
indicate that the effect of interest in the study have been
more important than the healthy volunteer effect, and
this might have caused some overestimation of the preva-
lence figures.
Selection bias might influence prevalence numbers
reported in this paper, but it is unlikely that the strong
association between non-musculoskeletal symptoms and
NPS is affected in such a way that it will alter our
conclusions.
One limitation of our cross-sectional design is that it
only allows evaluation of the association between vari-
ables and makes us unable to infer any cause-effect
relationship.
Assessment of symptoms
Given the complex and subjective nature of symptoms,
self-report methods are the best, if not the only possible
approach [31]. The quality of the data is dependent on
participants’ honesty and willingness to participate [32].
SNQ has been widely used in different versions, and is
considered to be well-validated and reliable [23].In the
Ullensaker study, we added a tenth body region (head)
to the original nine pain regions. The SNQ does not ask
directly whether the pain or discomfort experienced is
musculoskeletal in origin, although this may be an
implicit assumption.
We have modified the original symptom reporting
instrument SHC by omitting musculoskeletal-related
symptoms. The questions on pain symptoms asked for
were dichotomous, and included “pain and discomfort”;
hence we included individuals even “a little” bothered by
the non-musculoskeletal symptoms.
By using these instruments, we have a mis-match
between the 7-day time window in SNQ and the 30-day
window in SHC. The different time frames might influ-
ence the association between the two variables, but this
will probably weaken rather than strengthen the
association.
Some individuals might have a tendency to report any
symptoms, whereas others might consider similar symp-
toms to be insignificant and, hence, not report them. The
number of symptoms reported and the strong association
between NN-MS and NPS could, therefore, simply be a
result of reporting behaviour. It could be argued that per-
sonality traits may influence reporting patterns, but such
traits would at the same time influence the consequences
of the reported symptoms, such as health care use, sick-
ness absence and disability pensioning. In an earlier
paper from the Ullensaker Study, it was found that NPS
is an important predictor for future disability pensioning,
demonstrating that NPS has a strong predictive validity.
Consideration of statistical methods
There are methodological issues concerning dichotomisa-
tion that need to be considered. In order to be able to
count the number of symptoms, we needed a cut-off for
what was to be considered “symptom reported” and “symp-
tom not reported”. In line with the previous papers in the
Ullensaker study, we wanted to include all levels of intensity
for each symptom. Dichotomisation might in itself influ-
ence the association between data, introducing potential
information bias. Analyses moving the cut-off for dichoto-
misation to include only symptoms affecting respondents
to “some” or “severe” degree, gave reduced explanatory
power in NPS. Introduction of bias might also occur for the
imputation methods used, although our sensitivity analyses
indicated that our imputations were conservative.
Discussion of results
People report a great number of symptoms when
directly asked for them in surveys [2,33], symptoms that
do not necessarily reflect underlying disease. In our
study, 22.6% reported 10 or more symptoms out of 23.
Persons with medically unexplained symptoms (MUS)
usually report a number of symptoms [34], and most of
them would accordingly be in the groups reporting
most symptoms.
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Figure 2 T h en u m b e ro fp a i ns i t e s( N P S )i nr e l a t i o nt ot h e
three non-musculoskeletal symptoms with the highest
explanatory power in NPS (dizziness, sleep problems, and
tiredness) and the three non-musculoskeletal symptoms with
the lowest explanatory power in NPS (diarrhoea, constipation,
and eczema). The figure is based on the mean score of the
symptoms for each NPS-score.
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Page 6 of 8We have found a linear association between NN-MS
and NPS (Figure 1). If we are to regard the number of
symptoms reported as an indicator of health or well-
being, there seems to be a continuum of this state in
our population. Although our results are not unex-
pected, it is important to have the associations demon-
strated in population data. Even individual non-
musculoskeletal symptoms, although clinically varied in
nature, are related to NPS in an almost linear fashion.
Knowing the respondent’s answers to each of the 13
individual symptoms adds little in explaining NPS com-
pared to simply knowing the number.
The linear relationship between the number of muscu-
loskeletal and non-musculoskeletal symptoms might
indicate an internal association in symptom reporting
between symptoms, where, for example, individuals
experiencing pain will be prone to depression and sleep
problems. On the other hand, the strong linear relation-
ship between the number of musculoskeletal and non-
musculoskeletal symptoms supports the position that
the symptoms might share some common characteris-
tics and even common underlying causal factors. Hence,
symptom reporting could be looked upon as a phenom-
enon in itself, independent of diagnoses.
It is well known that some individuals with musculos-
keletal pain also report a variety of other symptoms.
Non-musculoskeletal symptoms were even reintroduced
in the 2010 preliminary criteria for fibromyalgia by the
American College of Rheumatology [19,35], after having
been abandoned in the 1990 version of the criteria, not
because they were irrelevant, but because they were
judged not to contribute to the specificity of the diagno-
sis of fibromyalgia [36].
In an earlier study on subjective health complaints in
the general population, a main finding was that there
were no sharp or obvious limits separating “normal” and
endurable pain and complaints and complaints that were
in need of professional help and might get labelled as a
specific diagnosis or syndrome [3]. In the contemporary
discussion of symptoms, most focus has been on medi-
cally unexplained symptoms and multisymptom report-
ing [10,12,33,37-40]. Some studies focusing on medically
unexplained symptoms (MUS) use a definition merely as
a function of the number of symptoms the individual
reports. Thus, the more symptoms you have, the more
likely it is that they are medically unexplained. For exam-
ple, the validated questionnaire PHQ-15 assesses 15
symptoms or symptom clusters that “account for more
than 90% of the physical complaints reported in the out-
patient setting” [2]. Kroenke et al. state that the PHQ
cannot distinguish between medically explained and
medically unexplained symptoms, but emphasize that
“the total symptom counts (including medically unex-
plained and explained) are predictive of somatoform
disorders and correlate strongly with psychological
distress, functional impairment and health care utiliza-
tion”[41-43]. The different medically unexplained syn-
dromes overlap, and the diagnoses are based entirely, or
in part, on symptoms widely reported in the general
population.
NPS has revealed itself to have strong predictive valid-
ity, and NN-MS seems to be another informative
dimension in describing the pattern of symptom report-
ing in the general population. Hence, the total burden
of symptoms as indicated by the number of symptoms
reported might be an interesting generic indicator of an
individual’s health or well-being, as well as his/her pre-
sent and future functioning, and may be worth further
investigations.
In our approach, based on the history of our research,
we have distinguished between musculoskeletal and
non-musculoskeletal symptoms. Other studies have dis-
tinguished between somatic and mental symptoms. Both
epidemiological and clinical research on symptom
reporting should avoid such distinctions and instead
include all relevant symptoms.
Symptom reporting is the main entrance into the
health care system. One implication of our findings is
that health professionals in general and GPs in particu-
lar might become more aware of the “normal” range of
symptom reporting in the population and, thereby, be
better equipped to decide which individuals should
undergo supplementary medical investigations. Research
on symptom reporting might also be an alternative
pathway to describe and possibly understand the medi-
cally unexplained multisymptom conditions.
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